3Zhao KL,Shi XH,Jiang GL,et al. Late course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma. Int J Radiat Oncol Biol Phys ,2004,60 : 123-129. 被引量:1
4Jin J, Liao ZX, Zhang Z, et al. Induction chemotherapy improved outcomes of patients with respectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys,2004, 60:427-436. 被引量:1
5Lee JL, Park SI, Kim SB, et al. A single institutional phase III trial of pre- operative chemotherapy with hyperfraetionation radiotherapy plus surgery versus surgery alone for respectable esophageal squamous cell carcinoma. Annals Oncology,2004,15:947-954. 被引量:1
6Delcambre C,Jacob JH,Pottier D, et al. Localized squamous-cell cancer of the esophagus: retrospective analysis of three treatmen schedules. Radiother Oncol, 2001,59 : 195-201. 被引量:1
7Liao Z, Zhang Z, Jin J, et al. Esophagectomy after concurrent chemoradio- therapy improves locoregional control in clinical stageII or III esophageal cancer patients. Int JRadiat Oncol Biol Phys,2004,60:1484-1493. 被引量:1
9Tachibana M, Yoshimura H, Kinugasa S, et al. Postoperative chemotherapy vs. chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial. EJSO, 2003,29:580-587. 被引量:1
3Lerut T, De Leyn P, Coosemans W, et al, Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg, 1992, 216:583-590. 被引量:1
4Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg, 1994, 220:364-373. 被引量:1
5Tai P, van Dyk J, Yu E, et al. Variability of target volume delineation in cervical esophageal cancer. Int J Radiat Oncol Bid Phys,1998,42:277-288. 被引量:1
6Abmad M, Nath R. Three-dimensional radiotherapy of head and neck and esophageal carcinomas: a monoisocentric treatment technique to achieve improved dose distributions. Int J Cancer,2001,96:55-65. 被引量:1
8Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.Int J Radiat Oncol Biol Phys,1989,16:1623-1630. 被引量:1
9Lyman JT.Complication probability as assessed from dose volume historgrams.Rad Res,1985,104:S13-S15. 被引量:1